Skip to content

HILO-HF Registry: High Versus Low SpO2 Oxygen Therapy in Patients With Acute Heart Failure

High Versus Low SpO2 Oxygen Therapy in Patients With Acute Heart Failure

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03110042
Enrollment
60
Registered
2017-04-12
Start date
2016-11-30
Completion date
2019-04-30
Last updated
2019-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Heart Failure

Brief summary

The HILO-HF Registry is a single centre registry that will be performed to provide information on the usual baseline oxygen saturation (SpO2) in patients presenting to ED with a primary ED diagnosis of AHF

Interventions

None listed

Sponsors

University of Alberta
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients \>40 years of age presenting to the ED with AHF * With or without tested BNP * With or without admission to hospital for treatment of HF\\ * Patients must be recruited within the first 24 hours of presenting to the ED.

Exclusion criteria

* Patients on home oxygen * Patients with known prior hypercapnic failure (PaCO2\>50 mmHg) * Asthma * Primary pulmonary hypertension * Patients requiring urgent positive pressure ventilation or intubation or on \>10 L/min oxygen

Design outcomes

Primary

MeasureTime frame
Change in blood oxygen saturation levels from baseline to 72 hours72 hours

Secondary

MeasureTime frame
Dyspnea on visual analogue scale (VAS) to 72 hours72 hours
Change in global symptoms using Patient Global Assessment (PGA) measure to 72 hours72 hours
Change in Peak Expiratory Flow72 hours
Rate of patients with Worsening Heart Failure7 days
30-day composite clinical event (all-cause mortality, HF readmission, days alive and out of hospital)30days

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026